home / stock / igx:cc / igx:cc news

IGX:CC News and Press, Intelgenx Technologies Corp. From 02/21/23

Stock Information
Company Name: Intelgenx Technologies Corp.
Stock Symbol: IGX:CC
Market: TSXC
Website: intelgenx.com
Menu
IGX:CC IGX:CC Quote IGX:CC Short IGX:CC News IGX:CC Articles IGX:CC Message Board
Get IGX:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
IGX:CC - IntelGenx Receives USPTO Notice of Allowance for Loxapine Orange Book Eligible Patent

SAINT LAURENT, Quebec, Feb. 21, 2023 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx”), a leader in pharmaceutical films, today announced that the United States Patent and Trademark Office (“USPTO”) has granted a Notice of Allowanc...
IGX:CC - IntelGenx Announces Research Collaboration with Renowned Neurologist to Evaluate Montelukast VersaFilm® for the Treatment of Parkinson's Disease

SAINT-LAURENT, Quebec, Feb. 09, 2023 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx”), a leader in pharmaceutical films, today announced a research collaboration with Per Svenningsson, MD, PhD, of the Karolinska Institute, to plan and conduct a...

IGX:CC - IntelGenx and Arwan Enter into a Supply Agreement for RIZAPORT® in MENA Countries

SAINT LAURENT, Quebec, Jan. 23, 2023 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, announced today that it has entered into an exclusive supply agreement (the “Agreement”) for RIZAPORT ® (th...

IGX:CC - IntelGenx Receives Fourth and Final Loan Tranche from atai

SAINT LAURENT, Quebec, Jan. 09, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company”) today announced that its wholly-owned subsidiary, IntelGenx Corp. (“IntelGenx”), has received a fourth and final term loan tranche (the “...
IGX:CC - IntelGenx Announces Collaboration with UPEI to Evaluate Acceptance and Preference of VetaFilm(TM) Platform in Dogs and Cats

SAINT LAURENT, Quebec, Dec. 07, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx”), a leader in pharmaceutical films, today announced a research collaboration with the University of Prince Edward Island (“UPEI”) to assess palat...

IGX:CC - IntelGenx Receives FDA PDUFA Date for RIZAFILM®

SAINT LAURENT, Quebec, Nov. 22, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that the U.S. Food and Drug Administration (”FDA”) has accepted for review its Class 2 respons...

IGX:CC - IntelGenx Reschedules Third Quarter 2022 Conference Call Due to Technical Issues Experienced Today by Webcast Vendor

SAINT LAURENT, Quebec, Nov. 10, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that its third quarter 2022 conference call, originally scheduled for today, will now be held tomorrow ...
IGX:CC - IntelGenx Reports Third Quarter 2022 Financial Results

SAINT LAURENT, Quebec, Nov. 10, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the third quarter ended September 30, 2022. All dollar amounts are expressed in U.S. currency, unless ot...

IGX:CC - IntelGenx Enters into Feasibility & Development Agreement For CBD-Infused VetaFilm(TM)

SAINT LAURENT, Quebec, Nov. 09, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx”), a leader in pharmaceutical films, today announced that it has entered into a Feasibility Study & Development Agreement (the “Agreementȁ...

IGX:CC - IntelGenx to Report Third Quarter 2022 Financial Results on November 10, 2022 - Conference Call to Follow

SAINT LAURENT, Quebec, Nov. 03, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release its third quarter 2022 financial results after market close on Thursday, November ...
Previous 10 Next 10